QuadraMed Appoints Thomas J. Dunn as Senior Vice President of Sales and Marketing
January 05 2010 - 8:01AM
Business Wire
QuadraMed® Corporation (NASDAQ:QDHC), announced today that
industry veteran Thomas J. Dunn has been named QuadraMed’s Senior
Vice President of Sales and Marketing. In this role, he will lead
the Company’s sales and marketing initiatives to further enhance
the company’s market position as a leading provider of healthcare
technologies and services that help turn quality care into positive
financial outcomes.
Dunn brings more than 25 years of enterprise healthcare
technology experience that includes the planning and execution of
competitive business strategies, creation of sustained business
partnerships, and a consistent track record of impressive revenue
growth and business expansion. Dunn began his career at Shared
Medical Systems (SMS), now part of Siemens Medical Solutions USA.
During his 22 years of service at SMS and Siemens Medical, he held
a variety of positions with steadily increasing leadership
responsibilities including services, operations, and sales,
culminating in his role as the national vice president of IT
Solutions.
From 2004 to 2007, he served as senior vice president at
Eclipsys Corporation, where he directed domestic sales and account
management. In his most recent role he served as vice president and
executive team member at CareMedic Corporation, a national provider
of Revenue-Cycle solutions for the healthcare industry. He holds a
Bachelor of Science degree in economics and business administration
from Ursinus College in Collegeville, Pennsylvania.
“Tom is an accomplished executive who will bring invaluable
leadership and sales management experience to QuadraMed,” said
Duncan James, QuadraMed’s President and Chief Executive Officer.
"His strong customer focus and proven track record in increasing
sales revenues will add considerable value towards helping the
company achieve its client-satisfaction and business
objectives.”
In connection with Dunn’s appointment as Senior Vice
President, Sales and Marketing, the company and Mr. Dunn
have entered into an Employment Agreement, Inducement Stock Option
Agreement and Proprietary Information and Non-Competition
Agreement. In connection with, and as an inducement to,
Mr. Dunn’s hiring, on January 5, 2010, the company
granted Mr. Dunn options to purchase 70,000 shares of the
company’s common stock at an exercise price equal to the company’s
closing stock price on Mr. Dunn's start date. The options have
a ten-year term and vest 25% on the first anniversary of the date
of grant and 75% in thirty-six equal monthly installments following
such anniversary. In addition, the options automatically vest upon
Mr. Dunn’s involuntary termination.
About QuadraMed Corporation
QuadraMed® – (NASDAQ: QDHC) is a leading provider of healthcare
technologies and services that help turn quality care into positive
financial outcomes. QuadraMed provides innovative solutions that
streamline processes, ensure compliance and help healthcare
professionals deliver quality patient care. Behind the Company's
products and services is a staff of 600 professionals whose
experience and dedication have earned QuadraMed the trust and
loyalty of clients at over 2,000 healthcare provider facilities.
For more information about QuadraMed, visit
http://www.quadramed.com.
Cautionary Statement on Risks Associated with QuadraMed
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995
that are subject to risks and uncertainties. The words “believe,”
“expect,” “target,” “goal,” “project,” “anticipate,” “predict,”
“intend,” “plan,” “estimate,” “may,” “will,” “should,” “could” and
similar expressions and their negatives are intended to identify
such statements. Forward-looking statements are not guarantees of
future performance, anticipated trends or growth in businesses, or
other characterizations of future events or circumstances and are
to be interpreted only as of the date on which they are made.
QuadraMed undertakes no obligation to update or revise any
forward-looking statement. You should not place undue reliance on
these forward-looking statements. Our actual results could differ
materially from those anticipated in these forward-looking
statements for many reasons, including the risks faced by QuadraMed
described in documents filed with the Securities and Exchange
Commission ("SEC") from time to time. QuadraMed’s SEC filings can
be accessed through the Investor Relations section of our website,
www.quadramed.com, or through the SEC’s EDGAR Database at
www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833).
QuadraMed is a registered trademark of QuadraMed Corporation.
All other trademarks are the property of their respective
holders.
Quadramed Corp (MM) (NASDAQ:QDHC)
Historical Stock Chart
From Jul 2024 to Aug 2024
Quadramed Corp (MM) (NASDAQ:QDHC)
Historical Stock Chart
From Aug 2023 to Aug 2024